By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


F. Hoffmann-La Roche Ltd. 

Group Headquarters
Grenzacherstrasse 124
Basel    CH-4070  Switzerland
Phone: 41-0-61-688-1111 Fax: 41-0-61-691-9391




Company News
F. Hoffmann-La Roche Ltd. (RHHBY) Release: Combination Of Bevacizumab And Lomustine With First Recurrence Of Glioblastoma Prolongs PFS But Not OS 11/23/2015 2:21:06 PM
2013 Facility of the Year Awards (FOYA) Winners Announced, Biogen Idec, Inc. (Massachusetts) (BIIB) and F. Hoffmann-La Roche Ltd. (RHHBY) Among Them 1/29/2013 11:26:45 AM
Acucela Inc. Appoints Former Bristol-Myers Squibb Company (BMY) and F. Hoffmann-La Roche Ltd. (RHHBY) Executive, Jaisim Shah, to the Company‚Äôs Board of Directors 8/3/2011 8:06:19 AM
Aureus Pharma to Participate in a European Consortium for Drug Cardiac Toxicity 10/30/2008 11:14:59 AM
Chugai Pharmaceutical Co., Ltd. (Japan) And F. Hoffmann-La Roche Ltd. (RHHBY) Release: Overseas Co-Promotion of Actemra(R), a Treatment for Rheumatoid Arthritis 5/8/2007 11:57:55 AM
Trimeris, Inc. (TRMS) and F. Hoffmann-La Roche Ltd. (RHHBY) Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors 3/16/2007 2:38:14 AM
Antisoma's Stock Falls On Phase III Miss With R154910/19/2005 5:11:05 PM
Odyssey Thera, Inc. Initiates Project With F. Hoffmann-La Roche Ltd. (RHHBY)10/19/2005 5:10:50 PM
F. Hoffmann-La Roche Ltd. (RHHBY) Provides Health Care Professionals Access To GeneEd Inc.'s Cutting-Edge Oncology e-Learning10/19/2005 5:09:57 PM
Gilead Sciences (Foster City, CA) (GILD) Delivers Termination Notice To Roche (RHHBY) For Tamiflu Development And Licensing Agreement10/19/2005 5:09:20 PM